Skip to main content
. Author manuscript; available in PMC: 2020 May 21.
Published in final edited form as: J Orthop Res. 2018 Jul 26;36(10):2648–2656. doi: 10.1002/jor.24048

Fig 4.

Fig 4.

Biochemical analysis. Sprifermin-treated constructs had significantly higher total and regional GAG content, as well as significantly higher collagen content in the core of the explant. The total and regional solid volume fractions (dry weight/wet weight) were significantly lower in the control group (n=15-23/group).